Monitoring singlet oxygen in situ with delayed chemiluminescence to deduce the effect of photodynamic therapy.

Yanchun Wei,Da Xing,Shiming Luo,Wei Xu,Qun Chen
DOI: https://doi.org/10.1117/1.2904961
IF: 3.758
2008-01-01
Journal of Biomedical Optics
Abstract:Singlet oxygen (O-1(2)) is an important factor mediating cell killing in photodynamic therapy (PDT). We previously reported that chemiluminescence (CL) can be used to detect O-1(2) production in PDT and linked the signal to the PDT-induced cytotoxicity in vitro. We develop a new CL detection apparatus to achieve in vivo measurements. The system utilizes a time-delayed CL signal to overcome the interference from scattered excitation light, thus greatly improving the accuracy of the detection. The system is tested on healthy skin of BALB/ca mouse for its feasibility and reliability. The CL measurement is made during a synchronized gating period of the irradiation light. After each PDT treatment and in situ CL measurement, the skin response is scored over a period of 2 weeks. A remarkable relationship is observed between the score and the CL, regardless of the PDT treatment protocol. Although there are many issues yet to be addressed, our results clearly demonstrate the feasibility of CL measurement during PDT and its potential for in vivo PDT dosimetry. This requires further investigations. (C) 2008 Society of Photo-Optical Instrumentation Engineers.
What problem does this paper attempt to address?